PriyaRastogiMD

PubMed

• Ten-year Update: NRG Oncology/NSABP B-42 Randomized Trial: Extended Letrozole Therapy in Early-stage Breast Cancer.
  Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, Barry C Lembersky, Jong-Hyeon Jeong, Charles E Geyer, Louis Fehrenbacher, Stephen K Chia, Adam M Brufsky, Janice M...> ;Journal of the National Cancer Institute. 2023 May 15
• Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epider...
  Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc Buyse, Charles E Geyer Jr, Luca Gianni, Andreas Schneeweiss, Pierfranco Conte, Martine Piccart, Herve Bo...> ;Journal of Clinical Oncology. 2023 Apr 19
• Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Can...
  Pierre Squifflet, Everardo D Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiss, Pierfranco Conte, Martine...> ;Journal of Clinical Oncology. 2023 Mar 28
• 7 citations
  Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned int...
  Stephen R D Johnston, Masakazu Toi, Joyce O'Shaughnessy, Priya Rastogi, Mario Campone, Patrick Neven, Chiun-Sheng Huang, Jens Huober, Georgina Garnica Jaliffe, Irfan C...> ;The Lancet. Oncology. 2023 Jan 1
• Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer...
  Charles E Geyer Jr, Hanna Bandos, Priya Rastogi, Samuel A Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J Ward, Jonathan Polikoff, Adam M Brufsky, Louise Provenc...> ;Breast Cancer Research and Treatment. 2022 Jun 1
• Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-3...
  Charles E Geyer Jr, Hanna Bandos, Priya Rastogi, Samuel A Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J Ward, Jonathan Polikoff, Adam M Brufsky, Louise Provenc...> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 34 citations
  Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
  Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, Timothy J Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A Ligibel, Dawn L Hershman, Ingrid A Mayer, Timothy J Hob...> ;JAMA. 2022 May 24
• 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
  Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nan Lin, Edith A. Perez, Lori J. Goldstein, Stephen Chia, S...> ;The New England Journal of Medicine. 2021 Dec 1
• 5 citations
  Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
  Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter Ansell, Mark A. Watson, Junu Bae, Mathew Cherian, Joyce O'Shaughnessy, Michael Untch, Hope S. Rugo, Jens Huobe...> ;NPJ Breast Cancer. 2021 Nov 11
• 11 citations
  Letter to the Editor for 'Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE...
  Nadia Harbeck, Priya Rastogi, Ashwin Shahir, S.R.D. Johnston, Joyce O'Shaughnessy> ;Annals of Oncology. 2021 Oct 28
• 113 citations
  Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
  N. Harbeck, Priya Rastogi, M. Martin, Sara M. Tolaney, Z-M Shao, Peter A. Fasching, C.-S. Huang, G.G. Jaliffe, A. Tryakin, Matthew P. Goetz, Hope S. Rugo, Elżbieta Sen...> ;Annals of Oncology. 2021 Sep 29
• 1 citations
  Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
  Pamela J. Goodwin, Ryan J. O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Karen A. Gelmon, Timothy J. Whelan, Jennifer A. Ligibel...> ;JNCI Cancer Spectrum. 2021 Sep 1
• 10 citations
  Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
  Pamela J. Goodwin, Ryan J. O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Margot J. Burnell, Rachel Vander Meer, Andrea Molckovsk...> ;NPJ Breast Cancer. 2021 Jun 8
• 333 citations
  Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
  Andrew Tutt, Judy Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susa...> ;The New England Journal of Medicine. 2021 Jun 3
• 2 citations
  NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
  Patricia A. Ganz, Reena S. Cecchini, Louis Fehrenbacher, Charles E. Geyer, Priya Rastogi, John Crown, M. Thirlwell, David M. Ellison, Jean Francois Boileau, Patrick J....> ;NPJ Breast Cancer. 2021 May 20
• 229 citations
  Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
  Stephen R. D. Johnston, Nadia Harbeck, Roberto Hegg, Masakazu Toi, Miguel Martín, Zhi Min Shao, Q. Zhang, Jorge Luis Martinez Rodriguez, Mario Campone, Erika Hamilton,...> ;Journal of Clinical Oncology. 2020 Sep 20
• 8 citations
  NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response
  Sandra M. Swain, Gong Tang, Heather Ann Brauer, David Goerlitz, Peter C. Lucas, André Robidoux, Brent T. Harris, Hanna Bandos, Yuqi Ren, Charles E. Geyer, Priya Rastog...> ;Clinical Cancer Research. 2020 Aug 15
• 9 citations
  Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadju...
  Pierfranco Conte, Andreas Schneeweiss, Sibylle Loibl, Eleftherios P. Mamounas, Gunter von Minckwitz, Max S. Mano, Michael Untch, Chiun-Sheng Huang, Norman Wolmark, Pri...> ;Cancer. 2020 Jul 1
• The effect of metformin vs placebo on sex hormones in CCTG MA.32.
  Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, Marguerite Ennis, Jennifer Ligibel, Lois Shepherd, Dawn L Hershman, Timothy Whelan, Vuk Stambolic, Ingrid Mayer, Ti...> ;Journal of the National Cancer Institute. 2020 Jun 4
• 126 citations
  NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by...
  Louis Fehrenbacher, Reena S. Cecchini, Charles E. Geyer, Priya Rastogi, Joseph P. Costantino, James N. Atkins, John Crown, Jonathan Polikoff, Jean Francois Boileau, Lo...> ;Journal of Clinical Oncology. 2020 Feb 10
• 26 citations
  A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
  Evandro de Azambuja, Noam Pondé, Marion Procter, Priya Rastogi, Reena S. Cecchini, Matteo Lambertini, Karla V. Ballman, Alvaro Moreno Aspitia, Dimitrios Zardavas, L. R...> ;Breast Cancer Research and Treatment. 2020 Jan 1
• 20 citations
  Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combi...
  Sandra M. Swain, Gong Tang, Peter C. Lucas, André Robidoux, David Goerlitz, Brent T. Harris, Hanna Bandos, Charles E. Geyer, Priya Rastogi, Eleftherios P. Mamounas, No...> ;Breast Cancer Research and Treatment. 2019 Aug 19
• 29 citations
  Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
  Rim S. Kim, Nan Song, Patrick G. Gavin, Roberto Salgado, Hanna Bandos, Zuzana Kos, Giuseppe Floris, Gert Van den Eynden, Sunil Badve, Sandra Demaria, Priya Rastogi, Lo...> ;Journal of the National Cancer Institute. 2019 Aug 1
• 2 citations
  Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials.
  Judah Abberbock, Stewart J. Anderson, Priya Rastogi, Gong Tang> ;Statistics in Medicine. 2019 Feb 10
• 63 citations
  Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, pha...
  Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong-Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Br...> ;The Lancet. Oncology. 2019 Jan 1
• Join now to see all

Lectures

• Selected Updates in Breast Cancer 
  2007 Annual Meeting, Chicago, Illinois, USA
• Selected Updates in Breast Cancer 
  American Society of Clinical Oncology, 2007 Annual Meeting, Chicago, Illinois, USA